Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Hair Growth Therapy(ies) for Androgenetic Alopecia

Hair Growth Therapy(ies) for Androgenetic Alopecia Abstract I read the excellent review and case report by Walsh et al1 that appeared in the December 1995 issue of the Archives relating to the impressive hair regrowth observed in a single subject with male pattern androgenetic alopecia. The authors also informed us that human trials using combinations of finasteride and minoxidil in androgenetic alopecia "are currently underway." I was surprised, however, that the authors had sufficient comfort at this time to recommend that "this regimen should be considered for the treatment of patients with mild to moderate androgenetic alopecia who desire medical therapy following informed consent." The authors describe the use of this regimen in a 32-year-old healthy white man with androgenetic alopecia. The regimen consists of a combination of topical solutions of minoxidil and tretinoin (final solution, 3% minoxidil and 0.01% tretinoin, with 1 mL applied twice daily to the balding scalp) combined with the References 1. Walsh DS, Dunn CL, James WD. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride . Arch Dermatol. 1995;131:1373-1375.Crossref 2. Savin RC, Atton AV. Minoxidil: update on its clinical role . Dermatol Clin. 1993; 11:55-64. 3. Code of Federal Regulations. Food and Drugs. 21CFR314.126. Washington DC: US Government Printing Office; 1994:141-143 (pts 300-499). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Hair Growth Therapy(ies) for Androgenetic Alopecia

Archives of Dermatology , Volume 132 (6) – Jun 1, 1996

Loading next page...
 
/lp/american-medical-association/hair-growth-therapy-ies-for-androgenetic-alopecia-Ogz5TyytQP
Publisher
American Medical Association
Copyright
Copyright © 1996 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1996.03890300144029
Publisher site
See Article on Publisher Site

Abstract

Abstract I read the excellent review and case report by Walsh et al1 that appeared in the December 1995 issue of the Archives relating to the impressive hair regrowth observed in a single subject with male pattern androgenetic alopecia. The authors also informed us that human trials using combinations of finasteride and minoxidil in androgenetic alopecia "are currently underway." I was surprised, however, that the authors had sufficient comfort at this time to recommend that "this regimen should be considered for the treatment of patients with mild to moderate androgenetic alopecia who desire medical therapy following informed consent." The authors describe the use of this regimen in a 32-year-old healthy white man with androgenetic alopecia. The regimen consists of a combination of topical solutions of minoxidil and tretinoin (final solution, 3% minoxidil and 0.01% tretinoin, with 1 mL applied twice daily to the balding scalp) combined with the References 1. Walsh DS, Dunn CL, James WD. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride . Arch Dermatol. 1995;131:1373-1375.Crossref 2. Savin RC, Atton AV. Minoxidil: update on its clinical role . Dermatol Clin. 1993; 11:55-64. 3. Code of Federal Regulations. Food and Drugs. 21CFR314.126. Washington DC: US Government Printing Office; 1994:141-143 (pts 300-499).

Journal

Archives of DermatologyAmerican Medical Association

Published: Jun 1, 1996

References